US HR95 | 2015-2016 | 114th Congress
Status
Sponsorship: Partisan Bill (Democrat 3)
Status: Introduced on February 5 2015 - 25% progression, died in committee
Action: 2015-02-06 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 5 2015 - 25% progression, died in committee
Action: 2015-02-06 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a "Valley of Death" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research. Recognizes: the value of biomedicine, biotechnology, and life sciences; the challenges those industries face; and the ways those challenges can be addressed.
Title
Recognizing the importance of transformative breakthroughs in biomedicine, biotechnology, and life sciences in the diagnosis, management, curing, and treatment of illness and the existence of a "Valley of Death" in biotechnology and life sciences funding that stifles innovation and impedes translational medical research.
Sponsors
| Rep. Juan Vargas [D-CA] | Rep. Michael Honda [D-CA] | Rep. Scott Peters [D-CA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2015-02-06 | House | Referred to the Subcommittee on Health. |
| 2015-02-05 | House | Referred to the House Committee on Energy and Commerce. |
| 2015-02-05 | House | Introduced in House |
Subjects
Advanced technology and technological innovations
Biological and life sciences
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Executive agency funding and structure
Food and Drug Administration (FDA)
Health
Health programs administration and funding
Health technology, devices, supplies
Medical research
Research administration and funding
Research and development
Biological and life sciences
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Executive agency funding and structure
Food and Drug Administration (FDA)
Health
Health programs administration and funding
Health technology, devices, supplies
Medical research
Research administration and funding
Research and development
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/114th-congress/house-resolution/95/all-info |
| Text | https://www.congress.gov/114/bills/hres95/BILLS-114hres95ih.pdf |
